Occurrence of highly fluoroquinolone-resistant and methicillin-resistant Staphylococcus aureus in domestic animals

Canadian Journal of Microbiology

Volumn 53, Issue 7, 2007, Pages 925-929

  Lin, Ann E ^a   Davies, Julian E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotic resistance; Community acquired infections; Pet associated infections; Strain phylogeny

Indexed keywords

ANIMALS; BACTERIA; MICROBIOLOGY; MUTAGENESIS;

ANTIBIOTIC RESISTANCE; COMMUNITY-ACQUIRED INFECTIONS; PET-ASSOCIATED INFECTIONS; STRAIN PHYLOGENY;

DRUG PRODUCTS;

CIPROFLOXACIN; ENROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM; DOMESTIC SPECIES; GENOTYPE; PATHOGEN; PHENOTYPE; PHYLOGENY; QUININE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DOG; DOMESTIC ANIMAL; GENE MUTATION; GENE SEQUENCE; GENOTYPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANIMALS, DOMESTIC; ANTI-INFECTIVE AGENTS; CAT DISEASES; CATS; CHICKENS; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; DISEASE RESERVOIRS; DNA GYRASE; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; METHICILLIN RESISTANCE; PHYLOGENY; POULTRY DISEASES; STAPHYLOCOCCUS AUREUS; ZOONOSES;

ANIMALIA; CANIS FAMILIARIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 35649022820     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W07-062     Document Type: Article

References (29)

1. Aldridge, K.E., Gelfand, M.S., Schiro, D.D., and Barg, N.L. 1992. The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital. An in vitro look at alternative antimicrobial agents. Diagn. Microbiol. Infect. Dis. 15: 601-608. doi:10.1016/0732-8893(90)90037-V.
2. Barton, M.D., Pratt, R., and Hart, W.S. 2003. Antibiotic resistance in animals. Commun. Dis. Intell. 27 (Suppl): S121-S126.
3. Cha, H.Y., Moon, D.C., Choi, C.H., Oh, J.Y., Jeong, Y.S., Lee, Y.C., et al. 2005. Prevalence of the ST239 clone of methicillin-resistant Staphylococcus aureus and differences in antimicrobial susceptibilities of ST239 and ST5 clones identified in a Korean hospital. J. Clin. Microbiol. 43: 3610-3614. doi:10.1128/JCM.43.8.3610-3614.2005.
4. Cook, P.P., Catrou, P., Gooch, M., and Holbert, D. 2006. Effect of reduction in ciprofloxacin use on prevalence of methicillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital. J. Hosp. Infect. 64: 348-351. doi:10.1016/j.jhin.2006.06.033.
5. Enright, M.C., Robinson, D.A., Randle, G., Feil, E.J., Grundmann, H., and Spratt, B.G. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. U.S.A. 99: 7687-7692. doi:10.1073/pnas.122108599.
6. Goldstein, F.W., and Acar, J.F. 1995. Epidemiology of quinolone resistance: Europe and North and South America. Drugs, 49 (Suppl 2): 36-42.
7. Ince, D., and Hooper, D.C. 2003. Quinolone resistance due to reduced target enzyme expression. J. Bacteriol. 185: 6883-6892. doi:10.1128/JB.185.23.6883-6892.2003.
8. Jacoby, G.A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41 (Suppl 2): S120-S126. doi:10.1086/428052.
9. Kalia, A., Rattan, A., and Chopra, P. 1999. A method for extraction of high-quality and high-quantity genomic DNA generally applicable to pathogenic bacteria. Anal. Biochem. 275: 1-5. doi:10.1006/abio.1999.4259.
10. Lapierre, P., Huletsky, A., Fortin, V., Picard, F.J., Roy, P.H., Ouellette, M., and Bergeron, M.G. 2003. Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus. J. Clin. Microbiol. 41: 3246-3251. doi:10.1128/JCM.41.7.3246-3251.2003.
11. Malik, S., Coombs, G.W., O'Brien, F.G., Peng, H., and Barton, M.D. 2006. Molecular typing of methicillin-resistant staphylococci isolated from cats and dogs. J. Antimicrob. Chemother. 58: 428-431. doi:10.1093/jac/dkl253.
12. Martinez, M., McDermott, P., and Walker, R. 2006. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J. 172: 10-28. doi:10.1016/j.tvjl.2005.07.010.
13. McClure, J.A., Conly, J.M., Lau, V., Elsayed, S., Louie, T., Hutchins, W., and Zhang, K. 2006. Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J. Clin. Microbiol. 44: 1141-1144. doi:10.1128/JCM.44.3. 1141-1144.2006.
14. Melter, O., Aires de Sousa, M., Urbaskova, P., Jakubu, V., Zemlickova, H., and de Lencastre, H. 2003. Update on the major clonal types of methicillin-resistant Staphylococcus aureus in the Czech Republic. J. Clin. Microbiol. 41: 4998-5005. doi:10.1128/JCM.41.11.4998-5005.2003.
15. Meunier, D., Acar, J.F., Martel, J.L., Kroemer, S., and Valle, M. 2004. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets. Int. J. Antimicrob. Agents, 24: 592-598.
16. Morris, D.O., Mauldin, E.A., O'Shea, K., Shofer, F.S., and Rankin, S.C. 2006. Clinical, microbiological, and molecular characterization of methicillin-resistant Staphylococcus aureus infections of cats. Am. J. Vet. Res. 67: 1421-1425. doi:10.2460/ajvr.67.8.1421.
17. Moshirfar, M., Mirzaian, G., Feiz, V., and Kang, P.C. 2006. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J. Cataract Refract. Surg. 32: 515-518. doi:10.1016/j.jcrs. 2005.12.108.
18. Munoz Bellido, J.L., Gutierrez Zufiaurre, M.N., Sanchez Hernandez, F.J., Yague Guirao, G., Segovia Hernandez, M., and Garcia-Rodriguez, J.A. 2002. In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents, 20: 61-64.
19. Sierra, J.M., Marco, F., Ruiz, J., Jimenez de Anta, M.T., and Vila, J. 2002. Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and unrelated strains of methicillin-susceptible and -resistant Staphylococcus aureus. Clin. Microbiol. Infect. 8: 781-790. doi:10.1046/j.1469-0691. 2002.00400.x.
20. Singer, R.S., Finch, R., Wegener, H.C., Bywater, R., Walters, J., and Lipsitch, M. 2003. Antibiotic resistance - the interplay between antibiotic use in animals and human beings. Lancet Infect. Dis. 3: 47-51. doi:10.1016/S1473-3099(03)00490-0.
21. Strommenger, B., Kehrenberg, C., Kettlitz, C., Cuny, C., Verspohl, J., Witte, W., and Schwarz, S. 2006. Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J. Antimicrob. Chemother. 57: 461-465. doi:10.1093/jac/dki471.
22. Tanaka, M., Wang, T., Onodera, Y., Uchida, Y., and Sato, K. 2000. Mechanism of quinolone resistance in Staphylococcus aureus. J. Infect. Chemother. 6: 131-139. doi:10.1007/s101560070010.
23. Tokue, Y., Sugano, K., Saito, D., Noda, T., Ohkura, H., Shimosato, Y., and Sekiya, T. 1994. Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing. Antimicrob. Agents Chemother. 38: 428-431.
24. Vancutsem, P.M., Babish, J.G., and Schwark, W.S. 1990. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet. 80: 173-186.
25. Watanabe, A., Kikuchi, T., Lutfor, A.B., Tokue, Y., Takahashi, H., Fujimura, S., et al. 1999. In vitro antimicrobial activity and penetration rate into sputum of gatifloxacin, a novel 6-fluoro-8-methoxy quinolone, and its therapeutic efficacy in respiratory infections. J. Infect. Chemother. 5: 149-155. doi:10.1007/s101560050025.
26. Weber, S.G., Gold, H.S., Hooper, D.C., Karchmer, A.W., and Carmeli, Y. 2003. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg. Infect. Dis. 9: 1415-1422.
27. Weese, J.S., Dick, H., Willey, B.M., McGeer, A., Kreiswirth, B.N., Innis, B., and Low, D.E. 2006. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet. Microbiol. 115: 148-155. doi:10.1016/j.vetmic.2006.01.004.
28. Wijaya, L., Hsu, L.Y., and Kurup, A. 2006. Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation. Ann. Acad. Med. Singapore, 35: 479-486.
29. Wisplinghoff, H., Ewertz, B., Wisplinghoff, S., Stefanik, D., Plum, G., Perdreau-Remington, F., and Seifert, H. 2005. Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998. J. Clin. Microbiol. 43: 5445-5451. doi:10.1128/JCM.43.11.5445-5451.2005.